Epi Vax Oncology, Inc. announced it raised $375,000 in an initial filing from an offering of $1.25 Million

Oct 07, 2019•almost 6 years ago

Amount Raised

$375,000

Round Type

seed

New YorkBiotechnology

Company Information

Company

EpiVax Oncology, Inc.

Location

180 Varick Street

New York, New York, United States

About

EpiVax Oncology, a precision cancer immunotherapy company, is developing mutanome-directed, neo-epitope personalized therapeutic vaccines. EpiVax Oncology’s therapeutic vaccines are customized and specifically designed for each patient’s tumors, leveraging advances in next generation immunology.

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Epi Vax Oncology, Inc. announced it raised $375,000 in an initial filing from an offering of $1.25 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information